OrIGINaLNI radOVI OrIGINaL arTICLEs Retrospective analysis of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular tumors
Heidenreich A, Ohlmann C, Hegele. repeat retroperitoneal lymphadenectomy in advanced testicular cancer. Eur Urol. 2005;54–71.
2.
Management of clinical stage a, B1 and B2 with nonseminomatous testicular tumors upfront retroperitoneal lymphadenectomy. Eur Urol. 2009;624.
3.
Motzer Rj, Bolger G, Boston B. Testicular cancer: clinical practice guidelines in oncology. Natl Compr Cancer New. 2006;1038–58.
4.
Albers P, F. Guidelines on testicular cancer. Eur Urol. 2005;885–94.
5.
Van As Nj G, Dc, Money-Kyrle J. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimizing the detection of relapse. Urol. 2007;500–3.
6.
Lowrance W, Ms C, Clark P. assessing retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? a European perspective. Eur Urol. 2008;1008–15.
7.
Heidenreich A, Thuer D, Polyakov S. Post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol. 2008;260–72.
8.
Heidenreich W. Laparascopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer: a European perspective. Eur Urol. 2008;260–72.
9.
High risk clinical stage a nonseminomatous testicular tumors: Primary retroperitoneal lymphadenectomy or cisplatin-based chemotherapy? Eur Urol. 2009;507.
10.
Lj. Primary chemotherapy in low clinical stage germ cell testicular tumors: a feasible mode of treatment. Eur Urol. 2010;(6):539.
11.
Chevreau C, Mozerolles C, M. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion. Eur Urol. 2044;209–14.
12.
High risk clinical stage a nonseminomatous testicular tumors: patterns of recurrence and outcome of treatment. Urology. 2007;164.
13.
Primary retroperitoneal lymphadenectomy or cisplatin-based chenmotherapy in clinical stage B1/B2 neseminomatous testicular tumors: Long-term results of the prospective non-randomized study. Eur Urol Meet. 2007;(7):137.
14.
Weissbach L, Maatz R, Flechtner B, H. rPLNd or primary chemotherapy in clinical stage IIa/B nonseminomatous germ cell tumors. results of a prospective multicenter trial including quality of life assessment. Eur Urol. 2000;582–94.
Capitanio U, Perrotte C, P. Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous germ cell tumors. Urology. 2009;(2):373–7.
18.
risks of uncontrolled retroperitoneum. ann surg Oncol. 2003;100–1.
19.
reoperative retroperitoneal surgery. Urol Clin North amer. 2007;227–30.
20.
Baniel. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and postchemotherapy. semin surg Oncol. 1999;263–7.
21.
Baniel J, Foster. Complications of primary retroperitoneal lymph node dissection for lowstage testicular cancer. World j Urol. 1994;139–42.
22.
analiza rezultata posthemioterapijske retroperitonealne limfadenektomije kod pacijenata sa intramedijarnim i lošim rizikom neseminomskih tumora testisa. Materia Medica. 2011;352–60.
23.
Patološki nalaz i klinički tok kod pacijenata sa metastazama neseminomskih testikularnih tumora kod kojih je primenjena retroperitonealna limfadenektomija posle multiplih hemoterapija. Materia Medica. 2011;195–202.
24.
E-Mail.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
